Share This
Rituximab
Rituximab, sold under the trade names Rituxan and MabThera, is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of B cells. Rituximab is used in the treatment of many lymphomas, leukemias, and some autoimmune disorders.
Rituximab was developed by IDEC...
Learn more about Rituximab »
Add More Topics
Save this view to a base, or just for yourself.
2 Science or Technology Company topics matching:
Filter this Collection
+
Genentech
Genentech Inc. (NYSE: DNA), a composite of Genetic Engineering Technology, Inc., is a leading biotechnology corporation, which was founded in 1976 by venture capitalist Robert A. Swanson and biochemist Dr. Herbert W. Boyer. Considered the...
Technology Focus:
View entire collection »Medical focus:
View entire collection »
Biogen Idec
Biogen Idec, Inc. (NASDAQ: BIIB) is a biotechnology company specializing in drugs for neurological disorders, autoimmune disorders and cancer. The company was formed in 2003 by the merger of Cambridge, Massachusetts-based Biogen Inc. and San Diego,...
